Screener
Thermo Fisher Scientific TMO Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Consolidated revenues by Business | ||||||
| Analytical Instruments | $1.85B+6.9% | $1.72B-0.1% | $2.22B+1.3% | $1.89B+4.7% | $1.73B-3.0% | |
| Laboratory Products and Biopharma Services | $6.69B+11.6% | $6.04B+7.0% | $6.38B+7.5% | $5.97B+4.0% | $6B— | |
| Life Sciences Solutions | $2.82B+12.6% | $2.64B+12.6% | $2.95B+13.1% | $2.59B+8.4% | $2.5B+6.1% | |
| Specialty Diagnostics | $1.21B+6.3% | $1.14B-0.5% | $1.22B+5.4% | $1.17B+4.0% | $1.13B+1.5% |
FAQ
- How does Thermo Fisher Scientific break its business down?
- Thermo Fisher Scientific (TMO) reports consolidated revenues by business across 4 parts — Analytical Instruments, Laboratory Products and Biopharma Services, Life Sciences Solutions and Specialty Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Thermo Fisher Scientific's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Thermo Fisher Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
